PRG Q1 2026 Earnings Massive EPS Beat Surprises But Market Response Remains Subdued PFG Q1 2026 Earnings EPS Beat Amid Modest Share Decline vTv Therapeutics Q1 2026 Earnings EPS Surges to 165 Far Above Estimates Despite No Reported Revenue ERAS Q1 2026 Earnings EPS Misses Estimates by Wide Margin as Stock Climbs Asana ASAN Q1 2026 Earnings EPS Beat Drives Modest Stock Uptick Dermata Therapeutics DRMA Q1 2026 Earnings Narrower Loss Surprises as PreRevenue Biotech Continues Pipeline Progress